EMAIL THIS PAGE TO A FRIEND

Journal of molecular medicine (Berlin, Germany)

A dual tyrosine kinase inhibitor lapatinib suppresses overexpression of matrix metallopeptidase 1 (MMP1) in endometrial cancer.


PMID 24820961

Abstract

Endometrial cancers have been recently molecularly characterized; amplifications of human epidermal growth factor receptor 2 (HER2) were seen in 25xa0% of the serous-like tumors, and mutations in the PI(3)K/AKT pathways were seen in 93xa0% of endometrioid tumors. These new findings about endometrial cancer suggest a potential for targeted therapy with lapatinib, a dual inhibitor of epidermal growth factor receptor and HER2 tyrosine kinases. However, the clinical efficacy of lapatinib in phase II clinical trials for the treatment of endometrial cancers was only minimal. In this study, we investigated the signaling changes induced by lapatinib in endometrial cancer, which may improve its therapeutic efficacy in molecularly selected patient groups. We identified one of the final molecular targets of lapatinib to be interstitial collagenase, matrix metallopeptidase 1 (MMP1). Lapatinib suppresses MMP1 through EGFR and HER2, and their downstream ERK and AKT signaling pathways. We also found that the activating protein-1 binding site of MMP1 promoter is required for its transcriptional activation, which may be unique for endometrial cancers. Our results also showed that forced expression of active ERK or active AKT mutants rescued MMP1 expression from lapatinib suppression, further suggesting the importance of molecular selection to find appropriate patients with endometrial cancer for future clinical trials with any targeted therapies. MMP1 expression was high in tissues and sera in patients with endometrial cancer. Lapatinib inhibited MMP1 via both HER2 and EGFR signaling pathways. Both AKT and ERK need to be inhibited for efficient MMP1 suppression by lapatinib. Activating protein-1 (AP-1) binding site of MMP1 promoter is uniquely required for MMP1 activation in endometrial cancer. Suppression of both c-fos and c-Jun bound to AP1 binding site is required for lapatinib inhibition.

Related Materials

Product #

Image

Description

Molecular Formula

Add to Cart

J104
Anti-c-Jun antibody produced in rabbit, affinity isolated antibody, lyophilized powder
SAB4300307
Anti-JUN (Ab-170) antibody produced in rabbit, affinity isolated antibody
SAB4300308
Anti-JUN (Ab-239) antibody produced in rabbit, affinity isolated antibody
SAB4300309
Anti-JUN (Ab-243) antibody produced in rabbit, affinity isolated antibody
SAB4300286
Anti-JUN (Ab-63) antibody produced in rabbit, affinity isolated antibody
SAB4300288
Anti-JUN (Ab-73) antibody produced in rabbit, affinity isolated antibody
SAB4300305
Anti-JUN (Ab-91) antibody produced in rabbit, affinity isolated antibody
SAB4300306
Anti-JUN (Ab-93) antibody produced in rabbit, affinity isolated antibody
AV100614
Anti-JUN (AB1) antibody produced in rabbit, affinity isolated antibody
AV100708
Anti-JUN (AB2) antibody produced in rabbit, affinity isolated antibody
AV100911
Anti-JUN (AB3) antibody produced in rabbit, affinity isolated antibody
SAB1406055
Anti-JUN antibody produced in mouse, purified immunoglobulin, buffered aqueous solution
AV38133
Anti-JUN antibody produced in rabbit, IgG fraction of antiserum
SAB2103656
Anti-JUN antibody produced in rabbit, affinity isolated antibody
AV42039
Anti-MMP1 (AB1) antibody produced in rabbit, IgG fraction of antiserum
AV42040
Anti-MMP1 (AB2) antibody produced in rabbit, IgG fraction of antiserum, lyophilized powder
SAB4501890
Anti-MMP1 (Cleaved-Phe100) antibody produced in rabbit, affinity isolated antibody
SAB1406131
Anti-MMP1 antibody produced in mouse, purified immunoglobulin, buffered aqueous solution
RAB0361
Human MMP-1 ELISA Kit, for serum, plasma, cell culture supernatant and urine
RAB0362
Human MMP-1 ELISA Kit, for cell and tissue lysates
EHU078751 MISSION® esiRNA, esiRNA human ERBB2 (esiRNA1)
EMU210421 MISSION® esiRNA, esiRNA targeting mouse Erbb2
SAB5300271
Monoclonal Anti-JUN antibody produced in mouse, clone 5B1, ascites fluid
SAB5300272
Monoclonal Anti-JUN antibody produced in mouse, clone 4H9, ascites fluid
SAB4100540
Monoclonal Anti-JUN antibody produced in mouse, clone JUN-A487, culture supernatant
SAB4100541
Monoclonal Anti-JUN antibody produced in mouse, clone JUN-B487, culture supernatant
PLA0273
Rabbit anti-c-Jun Antibody, Affinity Purified, Powered by Bethyl Laboratories, Inc.